# Next-generation of BBQ analogues that selectively target breast cancer

**Authors:** Jennifer R. Baker, Jayne Gilbert, Nicholas S. O’Brien, Cecilia C. Russell, Adam McCluskey, Jennette A. Sakoff

PMC · DOI: 10.3389/fchem.2024.1396105 · Frontiers in Chemistry · 2024-06-21

## TL;DR

This study explores new BBQ compounds that selectively inhibit breast cancer cell growth, especially in triple-negative cells, by interacting with the Aryl hydrocarbon Receptor.

## Contribution

The paper introduces BBQ analogues with enhanced selectivity for breast cancer cells and identifies key structural features affecting their potency.

## Key findings

- Removing the phenyl Cl in BBQ significantly enhances its growth inhibitory effect in breast cancer cells.
- Addition of Cl or NO2 to the naphthyl rings restores the potency of BBQ analogues.
- CYP1 and SULT1A1 metabolic pathways are crucial for the growth inhibitory effect of BBQ.

## Abstract

We previously reported on the interaction of 10-chloro-7H-benzo[de]benzo[4,5]imidazo[2,1-a]isoquinolin-7-one (10-Cl-BBQ) with the Aryl hydrocarbon Receptor (AhR) and selective growth inhibition in breast cancer cell lines. We now report on a library of BBQ analogues with substituents on the phenyl and naphthyl rings for biological screening. Herein, we show that absence of the phenyl Cl of 10-Cl-BBQ to produce the simple BBQ molecule substantially enhanced the growth inhibitory effect with GI50 values of 0.001–2.1 μM in select breast cancer cell lines MCF-7, T47D, ZR-75-1, SKBR3, MDA-MB-468, BT20, BT474 cells, while having modest effects of 2.1–7 μM in other cell lines including HT29, U87, SJ-G2, A2780, DU145, BE2-C, MIA, MDA-MB-231 or normal breast cells, MCF10A (3.2 μM). The most potent growth inhibitory effect of BBQ was observed in the triple negative cell line, MDA-MB-468 with a GI50 value of 0.001 μM, presenting a 3,200-fold greater response than in the normal MCF10A breast cells. Additions of Cl, CH3, CN to the phenyl ring and ring expansion from benzoimidazole to dihydroquinazoline hindered the growth inhibitory potency of the BBQ analogues by blocking potential sites of CYP1 oxidative metabolism, while addition of Cl or NO2 to the naphthyl rings restored potency. In a cell-based reporter assay all analogues induced 1.2 to 10-fold AhR transcription activation. Gene expression analysis confirmed the induction of CYP1 oxygenases by BBQ. The CYP1 inhibitor α-naphthoflavone, and the SULT1A1 inhibitor quercetin significantly reduced the growth inhibitory effect of BBQ, confirming the importance of both phase I and II metabolic activation for growth inhibition. Conventional molecular modelling/docking revealed no significant differences between the binding poses of the most and least active analogues. More detailed DFT analysis at the DSD-PBEP86/Def-TZVPP level of theory could not identify significant geometric or electronic changes which would account for this varied AhR activation. Generation of Fukui functions at the same level of theory showed that CYP1 metabolism will primarily occur at the phenyl head group of the analogues, and substituents within this ring lead to lower cytotoxicity.

## Linked entities

- **Genes:** AHR (aryl hydrocarbon receptor) [NCBI Gene 196], CYP1A1 (cytochrome P450 family 1 subfamily A member 1) [NCBI Gene 1543], SULT1A1 (sulfotransferase family 1A member 1) [NCBI Gene 6817]
- **Chemicals:** 10-Cl-BBQ (PubChem CID 1778614), BBQ (PubChem CID 86734), α-naphthoflavone (PubChem CID 11790), quercetin (PubChem CID 5280343)
- **Diseases:** breast cancer (MONDO:0004989)

## Full-text entities

- **Genes:** CYP1A1 (cytochrome P450 family 1 subfamily A member 1) [NCBI Gene 1543] {aka AHH, CP11, CYP1, CYPIA1, P1-450, P450-C}, SULT1A1 (sulfotransferase family 1A member 1) [NCBI Gene 6817] {aka HAST1/HAST2, P-PST, P-PST 1, PST, ST1A1, ST1A3}, AHR (aryl hydrocarbon receptor) [NCBI Gene 196] {aka FVH3, RP85, bHLHe76}
- **Diseases:** cytotoxicity (MESH:D064420), breast cancer (MESH:D001943)
- **Cell lines:** DU145 — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_0105), MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), BT474 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0179), MIA — Homo sapiens (Human), Pancreatic undifferentiated carcinoma, Cancer cell line (CVCL_0428), T47D — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0553), BE2-C — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_0529), BT20 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0178), MCF10A — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0598), U87 — Homo sapiens (Human), Glioblastoma, Cancer cell line (CVCL_0022), SKBR3 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0033), SJ-G2 — Homo sapiens (Human), Glioblastoma, Cancer cell line (CVCL_M141), MDA-MB-468 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0419), HT29 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0320), A2780 — Homo sapiens (Human), Ovarian endometrioid adenocarcinoma, Cancer cell line (CVCL_0134), MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), ZR-75-1 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0588)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11224556/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11224556/full.md

## References

66 references — full list in the complete paper: https://tomesphere.com/paper/PMC11224556/full.md

---
Source: https://tomesphere.com/paper/PMC11224556